These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 36113601)

  • 1. Hydrazinyl thiazole linked indenoquinoxaline hybrids: Potential leads to treat hyperglycemia and oxidative stress; Multistep synthesis, α-amylase, α-glucosidase inhibitory and antioxidant activities.
    Hameed S; Khan KM; Salar U; Özil M; Baltaş N; Saleem F; Qureshi U; Taha M; Ul-Haq Z
    Int J Biol Macromol; 2022 Nov; 221():1294-1312. PubMed ID: 36113601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel molecular hybrids of EGCG and quinoxaline: Potent multi-targeting antidiabetic agents that inhibit α-glucosidase, α-amylase, and oxidative stress.
    Kothari M; Kannan K; Sahadevan R; Sadhukhan S
    Int J Biol Macromol; 2024 Apr; 263(Pt 1):130175. PubMed ID: 38360242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroquinazolin-4(1H)-one derivatives as novel and potential leads for diabetic management.
    Babatunde O; Hameed S; Salar U; Chigurupati S; Wadood A; Rehman AU; Venugopal V; Khan KM; Taha M; Perveen S
    Mol Divers; 2022 Apr; 26(2):849-868. PubMed ID: 33650031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study.
    Hussain R; Iqbal S; Shah M; Rehman W; Khan S; Rasheed L; Rahim F; Dera AA; Kehili S; Elkaeed EB; Awwad NS; Bajaber MA; Alahmdi MI; Alrbyawi H; Alsaab HO
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting
    Gohar NA; Fayed EA; A Ammar Y; A Abu Ali O; Ragab A; Mahfoz AM; Abusaif MS
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2367128. PubMed ID: 38913598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regioselective syntheses of 2-oxopyridine carbonitrile derivatives and evaluation for antihyperglycemic and antioxidant potential.
    Saleem F; Haider M; Khan KM; Özil M; Baltaş N; Ul-Haq Z; Qureshi U; Salar U; Taha M; Hameed S; Ullah N
    Int J Biol Macromol; 2023 Jun; 241():124589. PubMed ID: 37116840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indenoquinoxaline-phenylacrylohydrazide hybrids as promising drug candidates for the treatment of type 2 diabetes: In vitro and in silico evaluation of enzyme inhibition and antioxidant activity.
    Hameed S; Saleem F; Özil M; Baltaş N; Salar U; Ashraf S; Ul-Haq Z; Taha M; Khan KM
    Int J Biol Macromol; 2024 Apr; 263(Pt 2):129517. PubMed ID: 38266833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioevaluation of synthetic pyridones as dual inhibitors of α-amylase and α-glucosidase enzymes and potential antioxidants.
    Saleem F; Khan KM; Ullah N; Özil M; Baltaş N; Hameed S; Salar U; Wadood A; Rehman AU; Kumar M; Taha M; Haider SM
    Arch Pharm (Weinheim); 2023 Jan; 356(1):e2200400. PubMed ID: 36284484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation.
    Khamees Thabet H; Ragab A; Imran M; Helal MH; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Rakan Alshammari M; S Abusaif M; A Ammar Y
    Eur J Med Chem; 2024 Sep; 275():116589. PubMed ID: 38878516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, α-glucosidase and α-amylase inhibitory activities, acute toxicity and molecular docking studies of thiazolidine-2,4-diones derivatives.
    Fettach S; Thari FZ; Hafidi Z; Tachallait H; Karrouchi K; El Achouri M; Cherrah Y; Sefrioui H; Bougrin K; Faouzi MEA
    J Biomol Struct Dyn; 2022 Nov; 40(18):8340-8351. PubMed ID: 33847536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel thiazole derivatives containing pyrazole scaffold as PPAR-γ Agonists, α-Glucosidase, α-Amylase and COX-2 inhibitors; Design, synthesis and in silico study.
    Fadaly WAA; Elshewy A; Nemr MTM; Abdou K; Sayed AM; Kahk NM
    Bioorg Chem; 2024 Nov; 152():107760. PubMed ID: 39197383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic Insights into the Inhibitory Activities of Chemical Constituents from the Fruits of Terminalia boivinii on α-Glucosidase.
    Dlamini BS; Chen CR; Chen YK; Hsu JL; Shih WL; Chang CI
    Chem Biodivers; 2022 Jul; 19(7):e202200137. PubMed ID: 35726787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses, in vitro α-amylase and α-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies.
    Yeye EO; Kanwal ; Mohammed Khan K; Chigurupati S; Wadood A; Ur Rehman A; Perveen S; Kannan Maharajan M; Shamim S; Hameed S; Aboaba SA; Taha M
    Bioorg Med Chem; 2020 Jun; 28(11):115467. PubMed ID: 32327353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of new indazole based dual inhibitors of α-glucosidase and α-amylase enzymes, their in vitro, in silico and kinetics studies.
    Rafique R; Khan KM; Arshia ; Kanwal ; Chigurupati S; Wadood A; Rehman AU; Karunanidhi A; Hameed S; Taha M; Al-Rashida M
    Bioorg Chem; 2020 Jan; 94():103195. PubMed ID: 31451297
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Zheng PF; Xiong Z; Liao CY; Zhang X; Feng M; Wu XZ; Lin J; Lei LS; Zhang YC; Wang SH; Xu XT
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1938-1951. PubMed ID: 34459690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study.
    Taha M; Alrashedy AS; Almandil NB; Iqbal N; Anouar EH; Nawaz M; Uddin N; Chigurupati S; Wadood A; Rahim F; Das S; Venugopal V; Nawaz F; Khan KM
    Int J Biol Macromol; 2021 Nov; 190():301-318. PubMed ID: 34481854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imidazole-thiadiazole hybrids: A multitarget de novo drug design approach, in vitro evaluation, ADME/T, and in silico studies.
    Maqbool M; Solangi M; Khan KM; Özil M; Baltaş N; Salar U; Tariq SS; Haq ZU; Taha M
    Arch Pharm (Weinheim); 2024 Sep; 357(9):e2400325. PubMed ID: 38885529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Acyl Thiotriazinoindole Based Pharmacophores: Design, Synthesis, and SAR Studies with Molecular Docking and Biological Activity Profiling against Urease, α-amylase, α-glucosidase, Antimicrobial, and Antioxidant Targets.
    Haider MB; Saeed A; Ahmed A; Azeem M; Ismail H; Mehmood S; Taslimi P; Shah SAA; Irfan M; El-Seedi HR
    Protein J; 2024 Oct; 43(5):1009-1024. PubMed ID: 39222239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition.
    Gummidi L; Kerru N; Ebenezer O; Awolade P; Sanni O; Islam MS; Singh P
    Bioorg Chem; 2021 Oct; 115():105210. PubMed ID: 34332231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-Amylase and Alpha-Glucosidase Enzyme Inhibition and Antioxidant Potential of 3-Oxolupenal and Katononic Acid Isolated from
    Alqahtani AS; Hidayathulla S; Rehman MT; ElGamal AA; Al-Massarani S; Razmovski-Naumovski V; Alqahtani MS; El Dib RA; AlAjmi MF
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.